speb/financial-data huggingface dataset:
BCAT cash_flow (annual, 2021-12-31) — Issuance Of Capital Stock: 0.00
BCAT cash_flow (annual, 2021-12-31) — Issuance Of Debt: 690034626.00
BCAT balance_sheet (annual, 2021-12-31) — Long Term Debt And Capital Lease Obligation: 690556896.00
BCAT cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 690034626.00
BCAT cash_flow (annual, 2021-12-31) — Net Common Stock Issuance: -13087303.00
BCAT balance_sheet (annual, 2021-12-31) — Net Debt: 689860503.00
BCAT cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: 690034626.00
BCAT cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: 690034626.00
BCAT cash_flow (annual, 2021-12-31) — Repurchase Of Capital Stock: -13087303.00
BCAT balance_sheet (annual, 2021-12-31) — Total Capitalization: 690556896.00
BCAT balance_sheet (annual, 2021-12-31) — Total Debt: 690556896.00
BCAT income_statement (annual, 2022-12-31) — +Operating Expense: 2161462.00
BCAT income_statement (annual, 2022-12-31) — +Total Revenue: -320362215.00
BCAT balance_sheet (annual, 2022-12-31) — Accounts Payable: 267231317.00
BCAT income_statement (annual, 2022-12-31) — Basic Average Shares: 114777109.00
BCAT income_statement (annual, 2022-12-31) — Basic EPS: -2.81
BCAT cash_flow (annual, 2022-12-31) — Beginning Cash Position: 42774035.00
BCAT balance_sheet (annual, 2022-12-31) — Capital Stock: 2102239188.00
BCAT balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 4104465.00
BCAT balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 30208465.00
BCAT cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -138909597.00
BCAT balance_sheet (annual, 2022-12-31) — Cash Financial: 4104465.00
BCAT cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 10475.00
BCAT cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -15351.00
BCAT cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -1200763.00
BCAT cash_flow (annual, 2022-12-31) — Change In Payable: 586541.00
BCAT cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 41745.00
BCAT cash_flow (annual, 2022-12-31) — Change In Receivables: 2928957.00
BCAT cash_flow (annual, 2022-12-31) — Change In Working Capital: 2351604.00
BCAT cash_flow (annual, 2022-12-31) — Changes In Cash: -12047292.00
BCAT balance_sheet (annual, 2022-12-31) — Common Stock: 2102239188.00
BCAT cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -138909597.00
BCAT balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1821348401.00
BCAT cash_flow (annual, 2022-12-31) — Common Stock Payments: -52768302.00
BCAT balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 24686402.00
BCAT income_statement (annual, 2022-12-31) — Diluted Average Shares: 114777109.00
BCAT income_statement (annual, 2022-12-31) — Diluted EPS: -2.81
BCAT income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -322523677.00
BCAT cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -208278.00
BCAT cash_flow (annual, 2022-12-31) — End Cash Position: 30518465.00
BCAT balance_sheet (annual, 2022-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 2065441932.00
BCAT cash_flow (annual, 2022-12-31) — Financing Cash Flow: -879907756.00
BCAT cash_flow (annual, 2022-12-31) — Free Cash Flow: 867860464.00
BCAT cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 1190332448.00
BCAT income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -82010002.00
BCAT income_statement (annual, 2022-12-31) — General And Administrative Expense: 1455149.00
BCAT income_statement (annual, 2022-12-31) — Interest Expense: 2900624.00
BCAT income_statement (annual, 2022-12-31) — Interest Income: 66928415.00
BCAT balance_sheet (annual, 2022-12-31) — Invested Capital: 1823153170.00
BCAT balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 2068639018.00
BCAT balance_sheet (annual, 2022-12-31) — Investments And Advances: 2068639018.00
BCAT cash_flow (annual, 2022-12-31) — Issuance Of Debt: 288724.00
BCAT balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1804769.00
BCAT cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 288724.00
BCAT cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -688518581.00
BCAT cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -52768302.00
BCAT balance_sheet (annual, 2022-12-31) — Net Debt: 1804769.00
BCAT income_statement (annual, 2022-12-31) — Net Income: -322523677.00
BCAT income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -322523677.00
BCAT income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -322523677.00
BCAT income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -322523677.00
BCAT income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -322523677.00
BCAT cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -322523677.00
BCAT income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -322523677.00
BCAT income_statement (annual, 2022-12-31) — Net Interest Income: 64027791.00
BCAT cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -688229857.00
BCAT cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -688229857.00
BCAT cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 0.00
BCAT balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 1821348401.00
BCAT income_statement (annual, 2022-12-31) — Normalized Income: -322523677.00
BCAT cash_flow (annual, 2022-12-31) — Operating Cash Flow: 867860464.00
BCAT income_statement (annual, 2022-12-31) — Operating Revenue: -320362215.00
BCAT balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 108135000.00
BCAT cash_flow (annual, 2022-12-31) — Other Non Cash Items: -2299911.00
BCAT income_statement (annual, 2022-12-31) — Other Operating Expenses: 706313.00
BCAT balance_sheet (annual, 2022-12-31) — Other Payable: 6535761.00
BCAT balance_sheet (annual, 2022-12-31) — Payables: 273767078.00
BCAT balance_sheet (annual, 2022-12-31) — Prepaid Assets: 15039.00
BCAT income_statement (annual, 2022-12-31) — Pretax Income: -322523677.00
BCAT balance_sheet (annual, 2022-12-31) — Receivables: 154455701.00
BCAT cash_flow (annual, 2022-12-31) — Repayment Of Debt: -688518581.00
BCAT cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -52768302.00
BCAT balance_sheet (annual, 2022-12-31) — Retained Earnings: -280890787.00
BCAT income_statement (annual, 2022-12-31) — Selling General And Administration: 1455149.00
BCAT balance_sheet (annual, 2022-12-31) — Share Issued: 108135000.00
BCAT balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1821348401.00
BCAT balance_sheet (annual, 2022-12-31) — Tangible Book Value: 1821348401.00
BCAT income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
BCAT income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
BCAT balance_sheet (annual, 2022-12-31) — Total Assets: 2253333180.00
BCAT balance_sheet (annual, 2022-12-31) — Total Capitalization: 1823153170.00
BCAT balance_sheet (annual, 2022-12-31) — Total Debt: 1804769.00
BCAT balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1821348401.00
BCAT balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 431984779.00
BCAT income_statement (annual, 2023-12-31) — +Operating Expense: 2178366.00
BCAT income_statement (annual, 2023-12-31) — +Total Revenue: 206902583.00
BCAT balance_sheet (annual, 2023-12-31) — Accounts Payable: 175163131.00
BCAT income_statement (annual, 2023-12-31) — Basic Average Shares: 106627196.00
BCAT income_statement (annual, 2023-12-31) — Basic EPS: 1.92
BCAT cash_flow (annual, 2023-12-31) — Beginning Cash Position: 30518465.00
BCAT balance_sheet (annual, 2023-12-31) — Capital Stock: 1990725834.00
BCAT balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 6926611.00
BCAT balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 34295611.00
BCAT cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -164289173.00
BCAT balance_sheet (annual, 2023-12-31) — Cash Financial: 6926611.00
BCAT cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -201.00
BCAT cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -203959.00
BCAT cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 5783207.00
BCAT cash_flow (annual, 2023-12-31) — Change In Payable: 672445.00
BCAT cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -1625.00
BCAT cash_flow (annual, 2023-12-31) — Change In Receivables: -433314.00
BCAT cash_flow (annual, 2023-12-31) — Change In Working Capital: 5816553.00
BCAT cash_flow (annual, 2023-12-31) — Changes In Cash: 3733646.00
BCAT balance_sheet (annual, 2023-12-31) — Common Stock: 1990725834.00
BCAT cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -164289173.00
BCAT balance_sheet (annual, 2023-12-31) — Common Stock Equity: 1853695864.00
BCAT cash_flow (annual, 2023-12-31) — Common Stock Payments: -11498106.00
BCAT balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 6314574.00
BCAT income_statement (annual, 2023-12-31) — Diluted Average Shares: 106627196.00
BCAT income_statement (annual, 2023-12-31) — Diluted EPS: 1.92
BCAT income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 204724217.00
BCAT cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 43500.00
BCAT cash_flow (annual, 2023-12-31) — End Cash Position: 34295611.00
BCAT balance_sheet (annual, 2023-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1981554567.00
BCAT cash_flow (annual, 2023-12-31) — Financing Cash Flow: -177592048.00
BCAT cash_flow (annual, 2023-12-31) — Free Cash Flow: 181325694.00
BCAT cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -27923182.00
BCAT income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -56580416.00
BCAT income_statement (annual, 2023-12-31) — General And Administrative Expense: 1314293.00
BCAT income_statement (annual, 2023-12-31) — Interest Expense: 1397752.00
BCAT income_statement (annual, 2023-12-31) — Interest Income: 61500230.00
BCAT balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 1983780928.00
BCAT balance_sheet (annual, 2023-12-31) — Investments And Advances: 1983780928.00
BCAT cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -1804769.00
BCAT cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -11498106.00
BCAT income_statement (annual, 2023-12-31) — Net Income: 204724217.00
BCAT income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 204724217.00
BCAT income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 204724217.00
BCAT income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 204724217.00
BCAT income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 204724217.00
BCAT cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 204724217.00
BCAT income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 204724217.00
BCAT income_statement (annual, 2023-12-31) — Net Interest Income: 60102478.00
BCAT cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -1804769.00
BCAT cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -1804769.00
BCAT cash_flow (annual, 2023-12-31) — Net Other Financing Charges: 0.00
BCAT balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 1853695864.00
BCAT income_statement (annual, 2023-12-31) — Normalized Income: 204724217.00
BCAT cash_flow (annual, 2023-12-31) — Operating Cash Flow: 181325694.00
BCAT income_statement (annual, 2023-12-31) — Operating Revenue: 206902583.00
BCAT balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 107461816.00
BCAT cash_flow (annual, 2023-12-31) — Other Non Cash Items: -1291894.00
BCAT income_statement (annual, 2023-12-31) — Other Operating Expenses: 864073.00
BCAT balance_sheet (annual, 2023-12-31) — Other Payable: 5539092.00
BCAT balance_sheet (annual, 2023-12-31) — Payables: 180702223.00
BCAT balance_sheet (annual, 2023-12-31) — Prepaid Assets: 16664.00
BCAT income_statement (annual, 2023-12-31) — Pretax Income: 204724217.00
BCAT balance_sheet (annual, 2023-12-31) — Receivables: 30220865.00
BCAT cash_flow (annual, 2023-12-31) — Repayment Of Debt: -1804769.00
BCAT cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -11498106.00
BCAT balance_sheet (annual, 2023-12-31) — Retained Earnings: -137029970.00
BCAT income_statement (annual, 2023-12-31) — Selling General And Administration: 1314293.00
BCAT balance_sheet (annual, 2023-12-31) — Share Issued: 107461816.00
BCAT balance_sheet (annual, 2023-12-31) — Stockholders Equity: 1853695864.00
BCAT balance_sheet (annual, 2023-12-31) — Tangible Book Value: 1853695864.00
BCAT income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
BCAT income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.21
BCAT balance_sheet (annual, 2023-12-31) — Total Assets: 2048314068.00
BCAT balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 1853695864.00
BCAT balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 194618204.00
BCAT balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 0.00
BCAT income_statement (annual, 2024-12-31) — +Operating Expense: 3254994.00
BCAT income_statement (annual, 2024-12-31) — +Total Revenue: 197673074.00
BCAT balance_sheet (annual, 2024-12-31) — Accounts Payable: 189885758.00
BCAT balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 189885758.00
BCAT income_statement (annual, 2024-12-31) — Basic Average Shares: 106239388.00
BCAT income_statement (annual, 2024-12-31) — Basic EPS: 1.83
BCAT cash_flow (annual, 2024-12-31) — Beginning Cash Position: 34295611.00
BCAT balance_sheet (annual, 2024-12-31) — Capital Stock: 1721534665.00
BCAT balance_sheet (quarterly, 2024-12-31) — Capital Stock: 1721534665.00
BCAT balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 6297866.00
BCAT balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 6297866.00
BCAT balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 62551866.00
BCAT balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Federal Funds Sold: 62551866.00
BCAT cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -281490156.00
BCAT balance_sheet (annual, 2024-12-31) — Cash Financial: 6297866.00
BCAT balance_sheet (quarterly, 2024-12-31) — Cash Financial: 6297866.00
BCAT cash_flow (annual, 2024-12-31) — Change In Accrued Expense: 30893.00
BCAT cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 21564.00
BCAT cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -7011877.00
BCAT cash_flow (annual, 2024-12-31) — Change In Payable: -909681.00
BCAT cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 1403.00
BCAT cash_flow (annual, 2024-12-31) — Change In Receivables: 2630711.00
BCAT cash_flow (annual, 2024-12-31) — Change In Working Capital: -5236987.00
BCAT cash_flow (annual, 2024-12-31) — Changes In Cash: 28032093.00
BCAT balance_sheet (annual, 2024-12-31) — Common Stock: 1721534665.00
BCAT balance_sheet (quarterly, 2024-12-31) — Common Stock: 1721534665.00
BCAT cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -281490156.00
BCAT balance_sheet (annual, 2024-12-31) — Common Stock Equity: 1721260401.00
BCAT balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 1721260401.00
BCAT cash_flow (annual, 2024-12-31) — Common Stock Payments: -45363387.00
BCAT balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 7848361.00
BCAT balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 7848361.00
BCAT income_statement (annual, 2024-12-31) — Diluted Average Shares: 106239388.00
BCAT income_statement (annual, 2024-12-31) — Diluted EPS: 1.83
BCAT income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 194418080.00
BCAT cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 224162.00
BCAT cash_flow (annual, 2024-12-31) — End Cash Position: 62551866.00
BCAT balance_sheet (annual, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1842903818.00
BCAT balance_sheet (quarterly, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1842903818.00
BCAT cash_flow (annual, 2024-12-31) — Financing Cash Flow: -326853543.00
BCAT cash_flow (annual, 2024-12-31) — Free Cash Flow: 354885636.00
BCAT cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 169582133.00
BCAT income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 27065996.00
BCAT income_statement (annual, 2024-12-31) — General And Administrative Expense: 2255645.00
BCAT income_statement (annual, 2024-12-31) — Interest Expense: 1404028.00
BCAT income_statement (annual, 2024-12-31) — Interest Income: 56852975.00
BCAT balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 1850607952.00
BCAT balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 1850607952.00
BCAT balance_sheet (annual, 2024-12-31) — Investments And Advances: 1850607952.00
BCAT balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 1850607952.00
BCAT cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -45363387.00
BCAT income_statement (annual, 2024-12-31) — Net Income: 194418080.00
BCAT income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 194418080.00
BCAT income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 194418080.00
BCAT income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 194418080.00
BCAT income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 194418080.00
BCAT cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 194418080.00
BCAT income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 194418080.00
BCAT income_statement (annual, 2024-12-31) — Net Interest Income: 55448947.00
BCAT cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 0.00
BCAT balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 1721260401.00
BCAT balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 1721260401.00
BCAT income_statement (annual, 2024-12-31) — Normalized Income: 194418080.00
BCAT cash_flow (annual, 2024-12-31) — Operating Cash Flow: 354885636.00
BCAT income_statement (annual, 2024-12-31) — Operating Revenue: 197673074.00
BCAT balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 104775271.00
BCAT balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 104775271.00
BCAT cash_flow (annual, 2024-12-31) — Other Non Cash Items: -3877590.00
BCAT income_statement (annual, 2024-12-31) — Other Operating Expenses: 999349.00
BCAT balance_sheet (annual, 2024-12-31) — Other Payable: 4659407.00
BCAT balance_sheet (quarterly, 2024-12-31) — Other Payable: 4659407.00
BCAT balance_sheet (annual, 2024-12-31) — Payables: 194545165.00
BCAT balance_sheet (quarterly, 2024-12-31) — Payables: 194545165.00
BCAT balance_sheet (annual, 2024-12-31) — Prepaid Assets: 15261.00
BCAT balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 15261.00
BCAT income_statement (annual, 2024-12-31) — Pretax Income: 194418080.00
BCAT balance_sheet (annual, 2024-12-31) — Receivables: 11134637.00
BCAT balance_sheet (quarterly, 2024-12-31) — Receivables: 11134637.00
BCAT cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -45363387.00
BCAT balance_sheet (annual, 2024-12-31) — Retained Earnings: -274264.00
BCAT balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -274264.00
BCAT income_statement (annual, 2024-12-31) — Selling General And Administration: 2255645.00
BCAT balance_sheet (annual, 2024-12-31) — Share Issued: 104775271.00
BCAT balance_sheet (quarterly, 2024-12-31) — Share Issued: 104775271.00
BCAT balance_sheet (annual, 2024-12-31) — Stockholders Equity: 1721260401.00
BCAT balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 1721260401.00
BCAT balance_sheet (annual, 2024-12-31) — Tangible Book Value: 1721260401.00
BCAT balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 1721260401.00
BCAT income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
BCAT income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
BCAT balance_sheet (annual, 2024-12-31) — Total Assets: 1924309716.00
BCAT balance_sheet (quarterly, 2024-12-31) — Total Assets: 1924309716.00
BCAT balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 1721260401.00
BCAT balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 1721260401.00
BCAT balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 203049315.00
BCAT balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 203049315.00
BCAT balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 197516624.00
BCAT balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 55300062.00
BCAT balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1721534665.00
BCAT balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 3878288.00
BCAT balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 48381288.00
BCAT balance_sheet (quarterly, 2025-06-30) — Cash Financial: 3878288.00
BCAT balance_sheet (quarterly, 2025-06-30) — Common Stock: 1721534665.00
BCAT balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1641742875.00
BCAT balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 18076927.00
BCAT balance_sheet (quarterly, 2025-06-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1722307534.00
BCAT balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 1779586803.00
BCAT balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 1779586803.00
BCAT balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1641742875.00
BCAT balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 104775271.00
BCAT balance_sheet (quarterly, 2025-06-30) — Other Payable: 5869473.00
BCAT balance_sheet (quarterly, 2025-06-30) — Payables: 203386097.00
BCAT balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 24951.00
BCAT balance_sheet (quarterly, 2025-06-30) — Receivables: 37770401.00
BCAT balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -79791790.00
BCAT balance_sheet (quarterly, 2025-06-30) — Share Issued: 104775271.00
BCAT balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1641742875.00
BCAT balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1641742875.00
BCAT balance_sheet (quarterly, 2025-06-30) — Total Assets: 1865763443.00
BCAT balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1641742875.00
BCAT balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 224020568.00
BCAT income_statement (annual, 2025-12-31) — +Operating Expense: 1609844.00
BCAT income_statement (annual, 2025-12-31) — +Total Revenue: 223604681.00
BCAT balance_sheet (annual, 2025-12-31) — Accounts Payable: 272680513.00
BCAT balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 272680513.00
BCAT cash_flow (annual, 2025-12-31) — Beginning Cash Position: 62551866.00
BCAT balance_sheet (annual, 2025-12-31) — Capital Stock: 1409050474.00
BCAT balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1409050474.00
BCAT balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 6754016.00
BCAT balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 6754016.00
BCAT balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 47207012.00
BCAT balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 47207012.00
BCAT cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -344703998.00
BCAT balance_sheet (annual, 2025-12-31) — Cash Financial: 6754016.00
BCAT balance_sheet (quarterly, 2025-12-31) — Cash Financial: 6754016.00
BCAT cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -69484.00
BCAT cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -129562.00
BCAT cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -530745.00
BCAT cash_flow (annual, 2025-12-31) — Change In Payable: -206107.00
BCAT cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 14918.00
BCAT cash_flow (annual, 2025-12-31) — Change In Receivables: -196832.00
BCAT cash_flow (annual, 2025-12-31) — Change In Working Capital: -1117812.00
BCAT cash_flow (annual, 2025-12-31) — Changes In Cash: -15191211.00
BCAT balance_sheet (annual, 2025-12-31) — Common Stock: 1409050474.00
BCAT balance_sheet (quarterly, 2025-12-31) — Common Stock: 1409050474.00
BCAT cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -344703998.00
BCAT balance_sheet (annual, 2025-12-31) — Common Stock Equity: 1595292372.00
BCAT balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 1595292372.00
BCAT balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 9178754.00
BCAT balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 9178754.00
BCAT income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 221994837.00
BCAT cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -153643.00
BCAT cash_flow (annual, 2025-12-31) — End Cash Position: 47207012.00
BCAT balance_sheet (annual, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1815819356.00
BCAT balance_sheet (quarterly, 2025-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1815819356.00
BCAT cash_flow (annual, 2025-12-31) — Financing Cash Flow: -344703998.00
BCAT cash_flow (annual, 2025-12-31) — Free Cash Flow: 329512787.00
BCAT cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: 112281056.00
BCAT income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 46469914.00
BCAT income_statement (annual, 2025-12-31) — General And Administrative Expense: 1108132.00
BCAT income_statement (annual, 2025-12-31) — Interest Expense: 1427350.00
BCAT income_statement (annual, 2025-12-31) — Interest Income: 45454106.00
BCAT balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 1817330211.00
BCAT balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 1817330211.00
BCAT balance_sheet (annual, 2025-12-31) — Investments And Advances: 1817330211.00
BCAT balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 1817330211.00
BCAT cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
BCAT cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
BCAT income_statement (annual, 2025-12-31) — Net Income: 221994837.00
BCAT income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 221994837.00
BCAT income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 221994837.00
BCAT income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 221994837.00
BCAT income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 221994837.00
BCAT cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 221994837.00
BCAT income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 221994837.00
BCAT income_statement (annual, 2025-12-31) — Net Interest Income: 44026756.00
BCAT cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
BCAT cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 0.00
BCAT cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 0.00
BCAT balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 1595292372.00
BCAT balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 1595292372.00
BCAT income_statement (annual, 2025-12-31) — Normalized Income: 221994837.00
BCAT cash_flow (annual, 2025-12-31) — Operating Cash Flow: 329512787.00
BCAT income_statement (annual, 2025-12-31) — Operating Revenue: 223604681.00
BCAT balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 104775271.00
BCAT balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 104775271.00
BCAT cash_flow (annual, 2025-12-31) — Other Non Cash Items: -3645294.00
BCAT income_statement (annual, 2025-12-31) — Other Operating Expenses: 501712.00
BCAT balance_sheet (annual, 2025-12-31) — Other Payable: 4426374.00
BCAT balance_sheet (quarterly, 2025-12-31) — Other Payable: 4426374.00
BCAT balance_sheet (annual, 2025-12-31) — Payables: 277106887.00
BCAT balance_sheet (quarterly, 2025-12-31) — Payables: 277106887.00
BCAT balance_sheet (annual, 2025-12-31) — Prepaid Assets: 343.00
BCAT balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 343.00
BCAT income_statement (annual, 2025-12-31) — Pretax Income: 221994837.00
BCAT balance_sheet (annual, 2025-12-31) — Receivables: 101180076.00
BCAT balance_sheet (quarterly, 2025-12-31) — Receivables: 101180076.00
BCAT income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
BCAT balance_sheet (annual, 2025-12-31) — Retained Earnings: 186241898.00
BCAT balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 186241898.00
BCAT income_statement (annual, 2025-12-31) — Selling General And Administration: 1108132.00
BCAT balance_sheet (annual, 2025-12-31) — Share Issued: 104775271.00
BCAT balance_sheet (quarterly, 2025-12-31) — Share Issued: 104775271.00
BCAT income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
BCAT balance_sheet (annual, 2025-12-31) — Stockholders Equity: 1595292372.00
BCAT balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1595292372.00
BCAT balance_sheet (annual, 2025-12-31) — Tangible Book Value: 1595292372.00
BCAT balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 1595292372.00
BCAT income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BCAT income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
BCAT balance_sheet (annual, 2025-12-31) — Total Assets: 1965717642.00
BCAT balance_sheet (quarterly, 2025-12-31) — Total Assets: 1965717642.00
BCAT balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 1595292372.00
BCAT balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1595292372.00
BCAT balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 370425270.00
BCAT balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 370425270.00
BCAT income_statement (annual, 2025-12-31) — Total Unusual Items: 0.00
BCAT income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
BCAX income_statement (annual, 2022-12-31) — +Operating Expense: 37656000.00
BCAX income_statement (annual, 2022-12-31) — +Total Revenue: 0.00
BCAX balance_sheet (annual, 2022-12-31) — Accounts Payable: 5137000.00
BCAX balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 2231000.00
BCAX cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
BCAX income_statement (annual, 2022-12-31) — Basic Average Shares: 15440460.00
BCAX income_statement (annual, 2022-12-31) — Basic EPS: -2.45
BCAX cash_flow (annual, 2022-12-31) — Beginning Cash Position: 4731000.00
BCAX cash_flow (annual, 2022-12-31) — Capital Expenditure: -192000.00
BCAX balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 0.00
BCAX balance_sheet (annual, 2022-12-31) — Capital Stock: 2000.00
BCAX balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 4158000.00
BCAX balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 4158000.00
BCAX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 31695000.00
BCAX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -192000.00
BCAX cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -32076000.00
BCAX cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 0.00
BCAX cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 5871000.00
BCAX cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -922000.00
BCAX cash_flow (annual, 2022-12-31) — Change In Working Capital: 4949000.00
BCAX cash_flow (annual, 2022-12-31) — Changes In Cash: -573000.00
BCAX balance_sheet (annual, 2022-12-31) — Common Stock: 2000.00
BCAX balance_sheet (annual, 2022-12-31) — Common Stock Equity: -98803000.00
BCAX balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 17583000.00
BCAX balance_sheet (annual, 2022-12-31) — Current Assets: 4984000.00
BCAX balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 0.00
BCAX balance_sheet (annual, 2022-12-31) — Current Liabilities: 23896000.00
BCAX cash_flow (annual, 2022-12-31) — Depreciation: 10000.00
BCAX cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 10000.00
BCAX cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 10000.00
BCAX income_statement (annual, 2022-12-31) — Diluted Average Shares: 15440460.00
BCAX income_statement (annual, 2022-12-31) — Diluted EPS: -2.45
BCAX income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -37845000.00
BCAX income_statement (annual, 2022-12-31) — EBIT: -37732000.00
BCAX income_statement (annual, 2022-12-31) — EBITDA: -37722000.00
BCAX cash_flow (annual, 2022-12-31) — End Cash Position: 4158000.00
BCAX cash_flow (annual, 2022-12-31) — Financing Cash Flow: 31695000.00
BCAX cash_flow (annual, 2022-12-31) — Free Cash Flow: -32268000.00
BCAX income_statement (annual, 2022-12-31) — General And Administrative Expense: 6344000.00
BCAX balance_sheet (annual, 2022-12-31) — Gross PPE: 636000.00
BCAX cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 1000.00
BCAX income_statement (annual, 2022-12-31) — Interest Expense: 112000.00
BCAX income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 112000.00
BCAX income_statement (annual, 2022-12-31) — Interest Income: 4000.00
BCAX income_statement (annual, 2022-12-31) — Interest Income Non Operating: 4000.00
BCAX balance_sheet (annual, 2022-12-31) — Interest Payable: 1000.00
BCAX balance_sheet (annual, 2022-12-31) — Invested Capital: -98803000.00
BCAX cash_flow (annual, 2022-12-31) — Investing Cash Flow: -192000.00
BCAX cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 31535000.00
BCAX balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 0.00
BCAX balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 0.00
BCAX income_statement (annual, 2022-12-31) — Net Income: -37845000.00
BCAX income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -37845000.00
BCAX income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -37845000.00
BCAX income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -37845000.00
BCAX income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -37845000.00
BCAX cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -37845000.00
BCAX income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -37845000.00
BCAX income_statement (annual, 2022-12-31) — Net Interest Income: -108000.00
BCAX income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -108000.00
BCAX balance_sheet (annual, 2022-12-31) — Net PPE: 636000.00
BCAX cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -192000.00
BCAX cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 31535000.00
BCAX balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -98803000.00
BCAX income_statement (annual, 2022-12-31) — Normalized EBITDA: -37722000.00
BCAX income_statement (annual, 2022-12-31) — Normalized Income: -37845000.00
BCAX cash_flow (annual, 2022-12-31) — Operating Cash Flow: -32076000.00
BCAX income_statement (annual, 2022-12-31) — Operating Income: -37656000.00
BCAX income_statement (annual, 2022-12-31) — Operating Revenue: 0.00
BCAX balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 51760925.00
BCAX balance_sheet (annual, 2022-12-31) — Other Current Assets: 826000.00
BCAX income_statement (annual, 2022-12-31) — Other Gand A: 2544000.00
BCAX income_statement (annual, 2022-12-31) — Other Income Expense: -80000.00
BCAX balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 1083000.00
BCAX balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 85000.00
BCAX income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -80000.00
BCAX balance_sheet (annual, 2022-12-31) — Other Properties: 636000.00
BCAX balance_sheet (annual, 2022-12-31) — Payables: 5137000.00
BCAX balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 22720000.00
BCAX balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1176000.00
BCAX balance_sheet (annual, 2022-12-31) — Preferred Securities Outside Stock Equity: 81525000.00
BCAX cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 31535000.00
BCAX income_statement (annual, 2022-12-31) — Pretax Income: -37844000.00
BCAX cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 160000.00
BCAX cash_flow (annual, 2022-12-31) — Purchase Of PPE: -192000.00
BCAX income_statement (annual, 2022-12-31) — Reconciled Depreciation: 10000.00
BCAX income_statement (annual, 2022-12-31) — Research And Development: 31312000.00
BCAX balance_sheet (annual, 2022-12-31) — Retained Earnings: -101036000.00
BCAX income_statement (annual, 2022-12-31) — Salaries And Wages: 3800000.00
BCAX income_statement (annual, 2022-12-31) — Selling General And Administration: 6344000.00
BCAX balance_sheet (annual, 2022-12-31) — Share Issued: 51760925.00
BCAX cash_flow (annual, 2022-12-31) — Stock Based Compensation: 810000.00
BCAX balance_sheet (annual, 2022-12-31) — Stockholders Equity: -98803000.00
BCAX balance_sheet (annual, 2022-12-31) — Tangible Book Value: -98803000.00
BCAX income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
BCAX income_statement (annual, 2022-12-31) — Tax Provision: 1000.00
BCAX income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
BCAX balance_sheet (annual, 2022-12-31) — Total Assets: 6703000.00
BCAX balance_sheet (annual, 2022-12-31) — Total Capitalization: -98803000.00
BCAX balance_sheet (annual, 2022-12-31) — Total Debt: 0.00
BCAX balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: -98803000.00
BCAX income_statement (annual, 2022-12-31) — Total Expenses: 37656000.00
BCAX balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 105506000.00
BCAX balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1719000.00
BCAX balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 81610000.00
BCAX income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -37656000.00
BCAX balance_sheet (annual, 2022-12-31) — Working Capital: -18912000.00
BCAX income_statement (annual, 2023-12-31) — +Operating Expense: 39889000.00
BCAX income_statement (annual, 2023-12-31) — +Total Revenue: 0.00
BCAX balance_sheet (annual, 2023-12-31) — Accounts Payable: 3186000.00
BCAX balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 4250000.00
BCAX cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 568000.00
BCAX income_statement (annual, 2023-12-31) — Basic Average Shares: 33984930.00
BCAX income_statement (annual, 2023-12-31) — Basic EPS: -1.53
BCAX cash_flow (annual, 2023-12-31) — Beginning Cash Position: 4158000.00
BCAX cash_flow (annual, 2023-12-31) — Capital Expenditure: -586000.00
BCAX balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 657000.00
BCAX balance_sheet (annual, 2023-12-31) — Capital Stock: 2000.00
BCAX balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 230440000.00
BCAX balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 230440000.00
BCAX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 272496000.00
BCAX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -586000.00
BCAX cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -45628000.00
BCAX cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -47000.00
BCAX cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -8663000.00
BCAX cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: -914000.00
BCAX cash_flow (annual, 2023-12-31) — Change In Working Capital: -9624000.00
BCAX cash_flow (annual, 2023-12-31) — Changes In Cash: 226282000.00
BCAX balance_sheet (annual, 2023-12-31) — Common Stock: 2000.00
BCAX balance_sheet (annual, 2023-12-31) — Common Stock Equity: -148769000.00
BCAX cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
BCAX balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 9872000.00
BCAX balance_sheet (annual, 2023-12-31) — Current Assets: 231073000.00
BCAX balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 285000.00
BCAX balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 285000.00
BCAX balance_sheet (annual, 2023-12-31) — Current Liabilities: 15085000.00
BCAX cash_flow (annual, 2023-12-31) — Depreciation: 19000.00
BCAX cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 19000.00
BCAX cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 19000.00
BCAX income_statement (annual, 2023-12-31) — Diluted Average Shares: 33984930.00
BCAX income_statement (annual, 2023-12-31) — Diluted EPS: -1.53
BCAX income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -51985000.00
BCAX income_statement (annual, 2023-12-31) — EBIT: -39889000.00
BCAX income_statement (annual, 2023-12-31) — EBITDA: -39870000.00
BCAX cash_flow (annual, 2023-12-31) — End Cash Position: 230440000.00
BCAX cash_flow (annual, 2023-12-31) — Financing Cash Flow: 272496000.00
BCAX cash_flow (annual, 2023-12-31) — Free Cash Flow: -46214000.00
BCAX income_statement (annual, 2023-12-31) — General And Administrative Expense: 9272000.00
BCAX balance_sheet (annual, 2023-12-31) — Gross PPE: 815000.00
BCAX cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 0.00
BCAX income_statement (annual, 2023-12-31) — Interest Expense: 0.00
BCAX income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 0.00
BCAX income_statement (annual, 2023-12-31) — Interest Income: 1314000.00
BCAX income_statement (annual, 2023-12-31) — Interest Income Non Operating: 1314000.00
BCAX balance_sheet (annual, 2023-12-31) — Interest Payable: 0.00
BCAX balance_sheet (annual, 2023-12-31) — Invested Capital: -148769000.00
BCAX cash_flow (annual, 2023-12-31) — Investing Cash Flow: -586000.00
BCAX cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 272347000.00
BCAX balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 372000.00
BCAX balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 372000.00
BCAX cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
BCAX income_statement (annual, 2023-12-31) — Net Income: -51985000.00
BCAX income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -51985000.00
BCAX income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -51985000.00
BCAX income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -51985000.00
BCAX income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -51985000.00
BCAX cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -51985000.00
BCAX income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -51985000.00
BCAX income_statement (annual, 2023-12-31) — Net Interest Income: 1314000.00
BCAX income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: 1314000.00
BCAX balance_sheet (annual, 2023-12-31) — Net PPE: 815000.00
BCAX cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -586000.00
BCAX cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: 272347000.00
BCAX balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -148769000.00
BCAX income_statement (annual, 2023-12-31) — Normalized EBITDA: -39870000.00
BCAX income_statement (annual, 2023-12-31) — Normalized Income: -51985000.00
BCAX cash_flow (annual, 2023-12-31) — Operating Cash Flow: -45628000.00
BCAX income_statement (annual, 2023-12-31) — Operating Income: -39889000.00
BCAX income_statement (annual, 2023-12-31) — Operating Revenue: 0.00
BCAX balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 51760925.00
BCAX balance_sheet (annual, 2023-12-31) — Other Current Assets: 633000.00
BCAX income_statement (annual, 2023-12-31) — Other Gand A: 9272000.00
BCAX income_statement (annual, 2023-12-31) — Other Income Expense: -13405000.00
BCAX cash_flow (annual, 2023-12-31) — Other Non Cash Items: 13495000.00
BCAX balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 2094000.00
BCAX balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 17000.00
BCAX income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -13405000.00
BCAX balance_sheet (annual, 2023-12-31) — Other Properties: 815000.00
BCAX balance_sheet (annual, 2023-12-31) — Payables: 3186000.00
BCAX balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 13058000.00
BCAX balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1742000.00
BCAX balance_sheet (annual, 2023-12-31) — Preferred Securities Outside Stock Equity: 367277000.00
BCAX balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
BCAX cash_flow (annual, 2023-12-31) — Preferred Stock Issuance: 272347000.00
BCAX income_statement (annual, 2023-12-31) — Pretax Income: -51980000.00
BCAX cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 149000.00
BCAX cash_flow (annual, 2023-12-31) — Purchase Of PPE: -586000.00
BCAX income_statement (annual, 2023-12-31) — Reconciled Depreciation: 19000.00
BCAX income_statement (annual, 2023-12-31) — Research And Development: 30617000.00
BCAX balance_sheet (annual, 2023-12-31) — Retained Earnings: -153021000.00
BCAX income_statement (annual, 2023-12-31) — Salaries And Wages: 5820000.00
BCAX cash_flow (annual, 2023-12-31) — Sale Of PPE: 0.00
BCAX income_statement (annual, 2023-12-31) — Selling General And Administration: 9272000.00
BCAX balance_sheet (annual, 2023-12-31) — Share Issued: 51760925.00
BCAX cash_flow (annual, 2023-12-31) — Stock Based Compensation: 1899000.00
BCAX balance_sheet (annual, 2023-12-31) — Stockholders Equity: -148769000.00
BCAX balance_sheet (annual, 2023-12-31) — Tangible Book Value: -148769000.00
BCAX income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
BCAX income_statement (annual, 2023-12-31) — Tax Provision: 5000.00
BCAX income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
BCAX balance_sheet (annual, 2023-12-31) — Total Assets: 233982000.00
BCAX balance_sheet (annual, 2023-12-31) — Total Capitalization: -148769000.00
BCAX balance_sheet (annual, 2023-12-31) — Total Debt: 657000.00
BCAX balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -148769000.00
BCAX income_statement (annual, 2023-12-31) — Total Expenses: 39889000.00
BCAX balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 382751000.00
BCAX balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 2909000.00
BCAX balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 367666000.00
BCAX income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -39889000.00
BCAX balance_sheet (annual, 2023-12-31) — Working Capital: 215988000.00
BCAX cash_flow (quarterly, 2024-09-30) — Capital Expenditure: -8000.00
BCAX cash_flow (quarterly, 2024-09-30) — Income Tax Paid Supplemental Data: 0.00
BCAX cash_flow (quarterly, 2024-09-30) — Issuance Of Capital Stock: 333479000.00
BCAX cash_flow (quarterly, 2024-09-30) — Net Preferred Stock Issuance: 0.00
BCAX balance_sheet (quarterly, 2024-09-30) — Preferred Securities Outside Stock Equity: 0.00
BCAX cash_flow (quarterly, 2024-09-30) — Preferred Stock Issuance: 0.00
BCAX income_statement (annual, 2024-12-31) — +Operating Expense: 82389000.00
BCAX income_statement (annual, 2024-12-31) — +Total Revenue: 0.00
BCAX balance_sheet (annual, 2024-12-31) — Accounts Payable: 4508000.00